Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

WATCHMAN for Concomitant Left Atrial Appendage Electrical Isolation and Occlusion to Treat Persistent Atrial Fibrillation Rhythm

NCT03835338 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT03835338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03835338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
WATCHMAN for Concomitant Left Atrial Appendage Electrical Isolation and Occlusion to Treat Persistent Atrial Fibrillation Rhythm
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Withdrawn
Start date
September 1, 2021
Completion date
April 30, 2024
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

persistent atrial fibrillation